{"id":934935,"date":"2026-02-06T08:00:40","date_gmt":"2026-02-06T13:00:40","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/mereo-biopharma-group-plc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-mreo\/"},"modified":"2026-02-06T08:00:40","modified_gmt":"2026-02-06T13:00:40","slug":"mereo-biopharma-group-plc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-mreo","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/mereo-biopharma-group-plc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-mreo\/","title":{"rendered":"Mereo BioPharma Group plc Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights \u2013 MREO"},"content":{"rendered":"

<\/p>\n

Mereo BioPharma Group plc Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights \u2013 MREO<\/b><\/p>\n

LOS ANGELES–(BUSINESS WIRE<\/a>)–The DJS Law Group<\/a> reminds investors of a class action lawsuit against Mereo BioPharma Group plc (\u201cMereo\u201d or \u201cthe Company\u201d) (NASDAQ: MREO<\/a>) for violations of \u00a7\u00a710(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.<\/p>\n

\nShareholders who purchased shares of MREO during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments. Appointment as lead plaintiff is not required to partake in any recovery.<\/p>\n

CLASS PERIOD:<\/b> June 5, 2023 to December 26, 2025<\/p>\n

DEADLINE: <\/b>April 6, 2026<\/p>\n

CASE DETAILS: <\/b>According to the Complaint, the Company made false and misleading statements to the market. Mereo misled investors about its Phase 3 ORBIT and COSMIC programs. Both programs failed to achieve their endpoints against placebo or bisphosphonate control groups, respectively. Based on these facts, Mereo\u2019s public statements were false and materially misleading throughout the class period.<\/p>\n

\nIf you are a shareholder who suffered a loss, contact us to participate<\/a>.<\/p>\n

WHY DJS LAW GROUP?<\/b> DJS Law Group\u2019s primary focus is to enhance investor return through balanced counseling and aggressive advocacy. We specialize in securities class actions, corporate governance litigation, and domestic\/international M&A appraisals. Our clients are some of the largest and most sophisticated hedge funds and alternative asset managers in the world. The litigation claims of our clients are extraordinarily valuable assets that demand respect, focus, and results.<\/p>\n

Join the case<\/a> to recover your losses.<\/p>\n

\nThis press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20260206087415\/en\/<\/a><\/span><\/p>\n

\nDavid J. Schwartz
\n
DJS Law Group
\n
274 White Plains Road, Suite 1
\n
Eastchester, NY 10709
\n
Phone: 914-206-9742
\n
Email: David@djslawllp.com<\/a><\/p>\n

KEYWORDS:<\/b> United States North America California<\/p>\n

INDUSTRY KEYWORDS:<\/b> Class Action Lawsuit Professional Services Legal<\/p>\n

MEDIA:<\/b><\/p>\n\n","protected":false},"excerpt":{"rendered":"

Mereo BioPharma Group plc Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights \u2013 MREO LOS ANGELES–(BUSINESS WIRE)–The DJS Law Group reminds investors of a class action lawsuit against Mereo BioPharma Group plc (\u201cMereo\u201d or \u201cthe Company\u201d) (NASDAQ: MREO) for violations of \u00a7\u00a710(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of MREO during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments. Appointment as lead plaintiff is not required to partake in any recovery. CLASS PERIOD: June 5, 2023 to December 26, 2025 DEADLINE: April 6, 2026 CASE DETAILS: According … <\/p>\n

Continue reading “Mereo BioPharma Group plc Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights \u2013 MREO”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-934935","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nMereo BioPharma Group plc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights \u2013 MREO - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/mereo-biopharma-group-plc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-mreo\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Mereo BioPharma Group plc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights \u2013 MREO - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Mereo BioPharma Group plc Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights \u2013 MREO LOS ANGELES–(BUSINESS WIRE)–The DJS Law Group reminds investors of a class action lawsuit against Mereo BioPharma Group plc (\u201cMereo\u201d or \u201cthe Company\u201d) (NASDAQ: MREO) for violations of \u00a7\u00a710(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of MREO during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments. Appointment as lead plaintiff is not required to partake in any recovery. CLASS PERIOD: June 5, 2023 to December 26, 2025 DEADLINE: April 6, 2026 CASE DETAILS: According … Continue reading "Mereo BioPharma Group plc Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights \u2013 MREO"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/mereo-biopharma-group-plc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-mreo\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-06T13:00:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20260206087415r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mereo-biopharma-group-plc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-mreo\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mereo-biopharma-group-plc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-mreo\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Mereo BioPharma Group plc Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights \u2013 MREO\",\"datePublished\":\"2026-02-06T13:00:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mereo-biopharma-group-plc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-mreo\\\/\"},\"wordCount\":347,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mereo-biopharma-group-plc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-mreo\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20260206087415r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mereo-biopharma-group-plc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-mreo\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mereo-biopharma-group-plc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-mreo\\\/\",\"name\":\"Mereo BioPharma Group plc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights \u2013 MREO - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mereo-biopharma-group-plc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-mreo\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mereo-biopharma-group-plc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-mreo\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20260206087415r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2026-02-06T13:00:40+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mereo-biopharma-group-plc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-mreo\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mereo-biopharma-group-plc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-mreo\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mereo-biopharma-group-plc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-mreo\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20260206087415r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20260206087415r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mereo-biopharma-group-plc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-mreo\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Mereo BioPharma Group plc Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights \u2013 MREO\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Mereo BioPharma Group plc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights \u2013 MREO - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/mereo-biopharma-group-plc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-mreo\/","og_locale":"en_US","og_type":"article","og_title":"Mereo BioPharma Group plc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights \u2013 MREO - Market Newsdesk","og_description":"Mereo BioPharma Group plc Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights \u2013 MREO LOS ANGELES–(BUSINESS WIRE)–The DJS Law Group reminds investors of a class action lawsuit against Mereo BioPharma Group plc (\u201cMereo\u201d or \u201cthe Company\u201d) (NASDAQ: MREO) for violations of \u00a7\u00a710(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of MREO during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments. Appointment as lead plaintiff is not required to partake in any recovery. CLASS PERIOD: June 5, 2023 to December 26, 2025 DEADLINE: April 6, 2026 CASE DETAILS: According … Continue reading \"Mereo BioPharma Group plc Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights \u2013 MREO\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/mereo-biopharma-group-plc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-mreo\/","og_site_name":"Market Newsdesk","article_published_time":"2026-02-06T13:00:40+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20260206087415r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mereo-biopharma-group-plc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-mreo\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mereo-biopharma-group-plc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-mreo\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Mereo BioPharma Group plc Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights \u2013 MREO","datePublished":"2026-02-06T13:00:40+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mereo-biopharma-group-plc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-mreo\/"},"wordCount":347,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mereo-biopharma-group-plc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-mreo\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20260206087415r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mereo-biopharma-group-plc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-mreo\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/mereo-biopharma-group-plc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-mreo\/","name":"Mereo BioPharma Group plc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights \u2013 MREO - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mereo-biopharma-group-plc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-mreo\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mereo-biopharma-group-plc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-mreo\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20260206087415r1&sid=flmnd&distro=nx&lang=en","datePublished":"2026-02-06T13:00:40+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mereo-biopharma-group-plc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-mreo\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/mereo-biopharma-group-plc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-mreo\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mereo-biopharma-group-plc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-mreo\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20260206087415r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20260206087415r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mereo-biopharma-group-plc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-mreo\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Mereo BioPharma Group plc Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights \u2013 MREO"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/934935","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=934935"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/934935\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=934935"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=934935"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=934935"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}